Lumora and Promega said this week that they have signed an agreement for the use of Promega's Ultra-Glo luciferase in Lumora's bioluminescent assay in real time, or BART, molecular diagnostics technology.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.
Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.
DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.
A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.